Article

  • The EMBO Journal (1997) 16, 3797 - 3804
  • doi:10.1093/emboj/16.13.3797

bold beta-catenin is a target for the ubiquitin–proteasome pathway

Hermann Aberle1, Andreas Bauer1, Jörg Stappert1, Andreas Kispert1 and Rolf Kemler1

  1. Max-Planck Institute for Immunobiology, Department of Molecular Embryology, Stübeweg 51, D-79108 Freiburg, Germany

Correspondence to:

Rolf Kemler, E-mail: kemler@immunbio.mpg.de

Received 7 February 1997; Revised 18 March 1997


beta-catenin is a central component of the cadherin cell adhesion complex and plays an essential role in the Wingless/Wnt signaling pathway. In the current model of this pathway, the amount of beta-catenin (or its invertebrate homolog Armadillo) is tightly regulated and its steady-state level outside the cadherin–catenin complex is low in the absence of Wingless/Wnt signal. Here we show that the ubiquitin-dependent proteolysis system is involved in the regulation of beta-catenin turnover. beta-catenin, but not E-cadherin, p120cas or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin. Mutagenesis experiments demonstrate that substitution of the serine residues in the glycogen synthase kinase 3beta (GSK3beta) phosphorylation consensus motif of beta-catenin inhibits ubiquitination and results in stabilization of the protein. This motif in beta-catenin resembles a motif in IkappaB (inhibitor of NFkappaB) which is required for the phosphorylation-dependent degradation of IkappaB via the ubiquitin–proteasome pathway. We show that ubiquitination of beta-catenin is greatly reduced in Wnt-expressing cells, providing the first evidence that the ubiquitin–proteasome degradation pathway may act downstream of GSK3beta in the regulation of beta-catenin.

  • Keywords:

    • beta-catenin,
    • GSK3beta,
    • proteasome,
    • ubiquitin